J. Kim

发表

Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.

Jiwon Kim, D. Kirn, S. Thorne, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect

Yu Seong Lee, C. Yun, J. Kim, 2006, Gene Therapy.

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy

C. Yun, K. Singha, R. Namgung, 2012, Cancer Gene Therapy.

Defining strategies to extend duration of gene expression from targeted compacted DNA vectors

P. Davis, A. Ziady, J. Kim, 2004, Gene Therapy.

The proteasome metabolizes peptide-mediated nonviral gene delivery systems

K. Rice, J. Kim, C-P Chen, 2005, Gene Therapy.

B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity

J. Kim, R. Barth, G. Shen, 2000, Gene Therapy.

Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer

C. Yun, H. Nam, S. W. Kim, 2014, Gene Therapy.

Evaluation of E1B-mutant Replicating Adenoviruses for Cancer Gene Therapy.

C. Yun, J. Kim, K. Jung, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition

C. Yun, J. Kim, J. Yoo, 2008, Gene Therapy.

Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor

C. Yun, J. Kim, J. Chang, 2001, Gene Therapy.

Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect

J. Seong, A. Yoon, C. Yun, 2009, Gene Therapy.